Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Wayne, Pennsylvania
- Most recent report
- 10-Q, filed Nov 5, 2026
- Incorporated
- Nevada
- Filings on record
- 816 filings
- On EDGAR
- CIK 1583648
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 63
News 8 of 217
Prospectuses and Registrations 8 of 72
- S-8 Registration statement for an employee plan Aug 4, 2026
- 424B5 Prospectus supplement for an offering Feb 26, 2026
- 424B5 Prospectus supplement for an offering Feb 24, 2026
- S-3 Shelf registration statement Jan 2, 2026
- S-8 Registration statement for an employee plan Feb 18, 2025
- 424B3 Prospectus supplement for an offering Jan 17, 2025
- S-1/A Registration statement for an offering, amended Jan 14, 2025
- S-1 Registration statement for an offering Dec 31, 2024
Proxies 8 of 22
- DEFA14A Extra proxy material Apr 30, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2026
- DEFA14A Extra proxy material Apr 30, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2025
- DEF 14A Proxy statement for a shareholder vote Nov 6, 2024
- DEFA14A Extra proxy material Apr 28, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2023
- DEFA14A Extra proxy material Apr 29, 2022
Ownership 8 of 354
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 28, 2026
- 4 Insider reported a trade Oct 23, 2026
- 144 Notice of a proposed sale of restricted stock Oct 21, 2026
- 4 Insider reported a trade Oct 14, 2026
- 144 Notice of a proposed sale of restricted stock Oct 13, 2026
- 4 Insider reported a trade Sep 18, 2026
- 144 Notice of a proposed sale of restricted stock Sep 16, 2026
- 4 Insider reported a trade Sep 15, 2026
Other 8 of 88
- ARS Annual report sent to shareholders Apr 30, 2026
- EFFECT Notice that a registration became effective Jan 29, 2026
- CORRESP Reply to SEC staff Jan 27, 2026
- UPLOAD Comment letter from SEC staff Jan 5, 2026
- ARS Annual report sent to shareholders Apr 30, 2025
- EFFECT Notice that a registration became effective Jan 16, 2025
- CORRESP Reply to SEC staff Jan 15, 2025
- UPLOAD Comment letter from SEC staff Jan 3, 2025
Everything here comes from Palvella Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.